Sticking with statins: Half of patients abandon the drugs within five years
There are ways of boosting adherence, including improving shared decision-making, a GP says
More than half of adults prescribed statins will discontinue treatment within the first five years of therapy, with many failing to reinitiate, an Australian study shows.
The findings, based on real-world data, highlight the challenges associated with adherence to long-term statin preventive therapy, the researchers say.
They found that, among patients who did restart treatment, switching statin type or uptitrating was associated with a lower risk of further discontinuation compared with patients
